Episode Details
Back to EpisodesTrumpRx Gains Momentum: 2 More Drug Companies Join
Published 1 week, 5 days ago
Description
Two more drug giants, AbbVie and Genentech, join Trumps TrumpRx program, reducing prices for uninsured and underinsured patients. AbbVie slashes Humiras cost by 86%, while Amgen adds Enbrel and Otezla. The program aims to match international prices and integrate discounts into the Great Healthcare Plan, potentially benefiting government insurance users.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/bff3928b3cb9dc47